Last updated on September 2018

Study to Evaluate Safety Tolerability and Efficacy of UCB7665 in Subjects With Primary Immune Thrombocytopenia

Brief description of study

The primary objective of the study is to check if an subcutaneous (sc) infusion of UCB7665 is safe and tolerated in subjects with primary immune thrombocytopenia.

Clinical Study Identifier: NCT02718716

Contact Investigators or Research Sites near you

Start Over

UCB Cares

Tp0001 405
Gießen, Germany
  Connect »